FDA Returns Disappointing News for ALS Stem Cell Therapy
PLOS: DNA Science
OCTOBER 19, 2023
Also recently, FDA’s Cellular, Tissue, and Gene Therapies Advisory Committe turned down a stem cell treatment for amyotrophic lateral sclerosis, aka ALS, Lou Gehrig’s disease, or motor neuron disease. The only treatment for ALS is a drug, Riluzole , taken as a tablet or a film. The pace though varies quite a lot.
Let's personalize your content